Katherine R. Tuttle, MD, FASN, is Executive Director for Research at Providence Inland Northwest Health and Professor of Medicine at the University of Washington. She is an internationally recognised leader in diabetic kidney disease and served as a senior investigator on the REMODEL trial

Dr Kar is a GP academic in the UK and is interested in complications of type 2 diabetes mellitus (T2DM). His research suggested that young age at T2DM onset may be associated with earlier microvascular complications than older-onset T2DM, and he is currently working on models using multi-omics and AI.

Dr. Yan Zeng, MD, PhD, endocrinologist at The Affiliated Hospital of Southwest Medical University (Sichuan, China), specializes in gut microbiota and metabolites in diabetic kidney disease. She has published 16 SCI-indexed papers, contributed to 10 research projects, and reviews for journals like J Adv Res and Diabetes Res Clin Pract.

Dr. Zhou Wen comes from China. She serves as the Head Nurse of the Internal Medicine Department in The Second Xiangya Hospital of Central South University and is also a Master's Supervisor. She possesses profound expertise and extensive research experience in the management of hemodialysis patients with diabetic nephropathy.

Dr. Zhang is physician, professor and received her M.D./PhD degree at Nanjing Medical University. She studied as visiting scholar at King’s College Hospital, London;Clinical Islet Laboratory, University of Alberta;Transplantation Research Lab, UCSF. She has been engaged in the clinic and scientific research. She has published over 80 scientific articles.

Dr. Khalid Siddiqui is an Associate Professor of Biochemistry at Kuwait University and a leading expert in diabetes related complications. After earning his Ph.D. from Goethe University, Germany, and completing postdoc training in the UK, His research focuses on addressing the high prevalence of diabetes across the Arab world .

Kanchana Perera is a PhD candidate at Western Sydney University investigating determinants of diabetic kidney disease, including familial risk, biomarkers, and metabolic interventions. Her research integrates epidemiological and molecular analyses to improve prevention and outcomes for Māori and Pasifika populations.

Professor Tim Davis is an academic endocrinologist based at Fremantle Hospital. He has been involved in epidemiological studies such as the Fremantle Diabetes Study and intervention trials starting with the UKPDS.